Communicable diseases
Researchers have conducted an in-depth review of the molecular epidemiology of hepatitis B and C virus infections in Asia, highlighting the need for further investigation into the relationship between viral genotypes and disease severity. The study, led by scientists at the National Institute of Infectious Diseases in Tokyo, provides a
Communicable diseases
Researchers in Spain have identified the symptoms associated with antiphospholipid syndrome (APS) in patients with chronic viral infections, such as hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) infection. A study published in Clinical Infectious Diseases analyzed the clinical features of 82 patients with APS, revealing a range
Communicable diseases
Virologists at Vanderbilt University, Tennessee, have shed light on the limited cell fusion capacity of HIV-1 until core maturation. They identified a link between HIV-1 core maturation and the virus' ability to fuse with target cells, demonstrating that immature HIV-1 particles are 5- to 10-fold less active in fusion
Communicable diseases
Researchers in the United States have made a striking connection between hepatitis C virus (HCV) infection and diabetic amyotrophy, a rare form of diabetic neuropathy. The study, published in the journal Endocrinologist, presents a case report of a patient with HCV infection who developed diabetic amyotrophy, and discusses the diagnosis,
Communicable diseases
Adenovirus-neutralizing antibodies play a crucial role in determining the effectiveness of vaccine and gene therapy vectors. Researchers from the Netherlands have developed a new method to quantify these antibodies, using luciferase transgene detection. This innovation enables the evaluation of preexisting immunity to adenovirus vectors, which can lead to inconsistent clinical
Communicable diseases
Researchers at Tokyo Medical and Dental University have found that a key protein from the hepatitis C virus (HCV) modulates apoptosis, or programmed cell death, in liver cells. The study, published in the Journal of Infectious Diseases, reveals that the nonstructural protein 5A (NS5A) of HCV inhibits apoptosis induced by
Communicable diseases
Corixa Corp. provided an update on two potential products containing its MPL adjuvant, which is currently licensed to GlaxoSmithKline (GSK) for use in several vaccines in development, including Cervarix for the prevention of human papillomavirus (HPV) infection and Simplirix for the prevention of genital herpes. GSK highlighted these programs as
Communicable diseases
Researchers at Istanbul University's Oncology Institute have conducted a study to investigate the relationship between p53 mutations and human papillomavirus (HPV) infection in colon cancer. The study analyzed 56 samples of HPV-positive tumor tissues and found only two mutations in the p53 gene, a rate significantly lower than
Communicable diseases
A recent study published in the European Journal of Clinical Microbiology & Infectious Diseases has investigated the effect of hepatitis C coinfection on the recovery of CD4+ T cells in HIV-infected patients undergoing highly active antiretroviral therapy (HAART). The study, conducted by J. Macias and colleagues at Valme University Hospital
